Exelixis (EXEL) is back in focus after reporting positive phase 3 results for its cancer drug zanzalintinib in metastatic colorectal cancer, along with plans for the STELLAR-316 trial with Natera. See ...

Recurring EBITDA was down to €67.6 million – or 6.9% of Group revenue, compared with €87.4 million, or 7.9% of sales, in 2023–2024. EBITDA suffered from the sharp decline in volumes in the ...

Carol M. Kopp edits features on a wide range of subjects for Investopedia, including investing, personal finance, retirement planning, taxes, business management, and career development. Monte Carlo ...

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Charlene Rhinehart is a CPA , CFE, chair of ...

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, ...

This is a concise Python 3 programming tutorial for people who think that reading is boring. I try to show everything with simple code examples; there are no long and complicated explanations with ...